In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pharming nets $61.5mm in IPO

Executive Summary

The Dutch transgenics company Pharming has gone public on the Easdaq exchange, selling 4.1mm shares at $15 (NLG30) per share. Net proceeds were about $61.5mm. The company had raised $24mm just a few weeks before in a mezzanine financing.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Transgenics
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies